Skip to main content
    M

    Monte Rosa Therapeutics Inc (GLUE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $9.07
    -0.09 (-0.98%)

    Market Cap: $800.67M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Monte Rosa Therapeutics Inc (GLUE) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Monte Rosa Therapeutics (GLUE) has a latest price of $9.07 on Nov 17, 2026, 64.8% below its 52-week high of $25.77. Its price fell 36.8% over the past 12 months. The month-end price fell 54.1% over the 5 years through Oct 2026, a compound annual decline of 14.4%.

    Price Chart

    From Jun 2021 to Oct 2026, its highest month-end close was $35.69 in Aug 2021 and its lowest $3.10 in Nov 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart GLUE with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GLUE.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 42.5%, and over 6 months it fell 48.4%. The month-end price rose 216.5% over the 3 years through Oct 2026, a compound annual rate of 46.8%.

    PeriodChange
    1 month-14.9%
    3 months-42.5%
    6 months-48.4%
    12 months-36.8%
    12 months, with dividends-36.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+216.5%+46.8%
    5 years-54.1%-14.4%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 125.9%, and its weakest was 2022, when it fell 62.7%.

    YearCloseChange
    2026 through Oct 2026$10.76-31.4%
    2025$15.68+125.9%
    2024$6.94+22.8%
    2023$5.65-25.8%
    2022$7.61-62.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 18.3% below its 50-day average of $11.10 and 45.5% below its 200-day average of $16.63.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$9.07
    52-week high$25.77-64.8%
    52-week low$8.95+1.3%
    50-day average$11.10-18.3%
    200-day average$16.63-45.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 64.3%.

    MeasureValue
    1-year beta0.93
    Largest fall, 1 year-64.2%
    Largest fall, 3 years-64.3%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About GLUE

    What is GLUE's 1-year price change?

    Monte Rosa Therapeutics's price fell 36.8% over the past 12 months. With dividends included, the 12-month total return was -36.8%.

    What is GLUE's 5-year price change?

    Monte Rosa Therapeutics's month-end price fell 54.1% over the 5 years through Oct 2026, a compound annual decline of 14.4%. These figures leave out dividends.

    What is GLUE's 52-week high and low?

    Monte Rosa Therapeutics's 52-week high is $25.77 and its 52-week low is $8.95. Its latest price of $9.07 on Nov 17, 2026 is 64.8% below the high.

    What is GLUE's beta?

    Monte Rosa Therapeutics's 1-year beta against the S&P 500 is 0.93, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 64.2%.

    Is the GLUE chart free?

    Yes. Advanced Charting for GLUE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.